Pierce GF - Search Results

1

Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer.

Rancourt C, Rogers BE, Sosnowski BA, Wang M, Piché A, Pierce GF, Alvarez RD, Siegal GP, Douglas JT, Curiel DT. Rancourt C, et al. Among authors: pierce gf. Clin Cancer Res. 1998 Oct;4(10):2455-61. Clin Cancer Res. 1998. PMID: 9796978

2

Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.

Gu DL, Gonzalez AM, Printz MA, Doukas J, Ying W, D'Andrea M, Hoganson DK, Curiel DT, Douglas JT, Sosnowski BA, Baird A, Aukerman SL, Pierce GF. Gu DL, et al. Among authors: pierce gf. Cancer Res. 1999 Jun 1;59(11):2608-14. Cancer Res. 1999. PMID: 10363982

3

Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines.

Chandler LA, Sosnowski BA, Greenlees L, Aukerman SL, Baird A, Pierce GF. Chandler LA, et al. Among authors: pierce gf. Int J Cancer. 1999 May 5;81(3):451-8. doi: 10.1002/(sici)1097-0215(19990505)81:3<451::aid-ijc20>3.0.co;2-h. Int J Cancer. 1999. PMID: 10209961

4

Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand.

Hoganson DK, Sosnowski BA, Pierce GF, Doukas J. Hoganson DK, et al. Among authors: pierce gf. Mol Ther. 2001 Jan;3(1):105-12. doi: 10.1006/mthe.2000.0222. Mol Ther. 2001. PMID: 11162317 Free article.

5

Targeted delivery of DNA encoding cytotoxic proteins through high-affinity fibroblast growth factor receptors.

Hoganson DK, Chandler LA, Fleurbaaij GA, Ying W, Black ME, Doukas J, Pierce GF, Baird A, Sosnowski BA. Hoganson DK, et al. Among authors: pierce gf. Hum Gene Ther. 1998 Nov 20;9(17):2565-75. doi: 10.1089/hum.1998.9.17-2565. Hum Gene Ther. 1998. PMID: 9853523

6

Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways.

Doukas J, Hoganson DK, Ong M, Ying W, Lacey DL, Baird A, Pierce GF, Sosnowski BA. Doukas J, et al. Among authors: pierce gf. FASEB J. 1999 Aug;13(11):1459-66. doi: 10.1096/fasebj.13.11.1459. FASEB J. 1999. PMID: 10428769

7

FGF2-targeted adenoviral vectors for systemic and local disease.

Sosnowski BA, Gu DL, D'Andrea M, Doukas J, Pierce GF. Sosnowski BA, et al. Among authors: pierce gf. Curr Opin Mol Ther. 1999 Oct;1(5):573-9. Curr Opin Mol Ther. 1999. PMID: 11249664 Review.

8

Targeting DNA to cells with basic fibroblast growth factor (FGF2).

Sosnowski BA, Gonzalez AM, Chandler LA, Buechler YJ, Pierce GF, Baird A. Sosnowski BA, et al. Among authors: pierce gf. J Biol Chem. 1996 Dec 27;271(52):33647-53. doi: 10.1074/jbc.271.52.33647. J Biol Chem. 1996. PMID: 8969234 Free article.

9

Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein.

Chandler LA, Sosnowski BA, McDonald JR, Price JE, Aukerman SL, Baird A, Pierce GF, Houston LL. Chandler LA, et al. Among authors: pierce gf. Int J Cancer. 1998 Sep 25;78(1):106-11. doi: 10.1002/(sici)1097-0215(19980925)78:1<106::aid-ijc17>3.0.co;2-9. Int J Cancer. 1998. PMID: 9724101

10

FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation.

Chandler LA, Doukas J, Gonzalez AM, Hoganson DK, Gu DL, Ma C, Nesbit M, Crombleholme TM, Herlyn M, Sosnowski BA, Pierce GF. Chandler LA, et al. Among authors: pierce gf. Mol Ther. 2000 Aug;2(2):153-60. doi: 10.1006/mthe.2000.0102. Mol Ther. 2000. PMID: 10947943 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters